FindTrial
Sign In

Premedication with pronase and simethione improves visibility during gastroendoscopy: a prospective, multi-center, double-blind, randomized controlled trial

Premedication with pronase and simethione improves visibility during gastroendoscopy: a prospective, multi-center, double-blind, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15006033
Enrollment
Unknown
Registered
2015-03-02
Start date
2011-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

improves visibility during gastroendoscopy

Interventions

Gold Standard:
Index test:

Sponsors

Department of Gastroenterology, Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients are between 18-65 years old;

Exclusion criteria

Exclusion criteria: 1. Patients were pregnant or lactating women; 2. Patients were allergic to premedication agents; 3. Patients with a history of UGI surgery.

Design outcomes

Primary

MeasureTime frame
visibility during gastroendoscopy;—

Countries

China

Contacts

Public ContactLi Zhaoshen
zhsli@81890.net+86 021-81873241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026